Table 4.
Q1 | Q2 | Q3 | Q4 | |
---|---|---|---|---|
(n = 1235) | (n = 1236) | (n = 1236) | (n = 1235) | |
AMA in µg/(L*h) (SD) | 9.416 (1.21) | 11.66 (0.46) | 13.39 (0.57) | 17 (3) |
AMA range | 3.8–10.86 | 10.86–12.47 | 12.47–14.47 | 14.47–72.15 |
All-cause mortality | ||||
Number of events | 310 | 302 | 331 | 418 |
Hazard ratio (95% CI) | (ref) | 0.994 (0.847–1.166)n.s. | 1.031 (0.882–1.205)n.s. | 1.269 (1.094–1.473)*** |
Cardiovascular mortality | ||||
Number of events | 94 | 106 | 114 | 166 |
Hazard ratio (95% CI) | (ref) | 1.172 (0.887–1.548)n.s. | 1.169 (0.888–1.540)n.s. | 1.632 (1.263–2.110)**** |
n.s. not significant; ***p = 0.002; ****p < 0.0001. Cox proportional hazards models were adjusted for age, sex, current smoking, use of antihypertensive medication, systolic blood pressure, diabetes mellitus, body mass index, LDL cholesterol and HDL cholesterol.